3-Dimensional Pharmaceuticals Selected Financial Information Expected net income after tax next year before new $45 million financing Sinking-fund payments due next year on existing debt $14 million Interest due next year on existing debt $15 million Company tax rate 36% Common stock price, per share Common shares outstanding $20 $18 million Please refer to the financial information for 3-Dimensional Pharmaceuticals above. For next year, calculate 3-Dimensional Pharmaceuticals' times-burden-covered ratio if 3-Dimensional Pharmaceuticals sells 2 million new shares at $20 a share. O 1.89 O 1.89 2.10 O2.31 Next ->